Delafloxacin meglumine-
1 Inquiries
352458-37-8
98%
Hangzhou
1kg/bag
2024-12-31
Gadoterate Meglumine,Gadoteridol,Gadobutrol,Iopamidol,iohexol,Ioversol
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceDelafloxacin meglumine (Baxdela, WQ-3034, ABT-492, RX-3341; Melinta Therapeutics) was approved by the U.S. Food and Drug Administration (FDA) in June 2017 for the treatment of acute bacterial skin and skin structure infections on the basis of data from two phase III trials.Basic Info
-
Product Name:
Delafloxacin meglumine
Other Name:100850;ABT 492 meglumine (Delafloxacin meglumine);Delafloxacin meglumine (ABT492 meglumine;(2R,3R,4R,5S)-2,3,4,5-tetrahydroxy-6-(MethylaMino)hexyl 1-(6-aMino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate;ABT 492 MegluMine;ABT492 MegluMine;ABT-492 MegluMine;Delafloxacin (MegluMine)
CAS No.:352458-37-8
Molecular Formula:C18H12ClF3N4O4.C7H17NO5
InChIKeys:AHJGUEMIZPMAMR-KUAVVOKVNA-N
Molecular Weight:635.97
Color/Form:Off-white to yellow
Categories:
Characteristics-
Critical Temperature & Pressure:
under inert gas (nitrogen or Argon) at 2–8 °C
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Gadoterate Meglumine,Gadoteridol,Gadobutrol,Iopamidol,iohexol,Ioversol
-
Location:
NO.58 Xiahong Road, Hi-tech Industrial Development Zone, Anqing City, Anhui Province
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
30
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
Above 1000
-
Year of Establishment:
2018
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
Pakistan
Delafloxacin Meglumine
5 KG Nov 21, 2025 Post an enquiry for this product